Boston Scientific cuts annual forecast after quarterly profit falls
Boston Scientific (BSX) reported Q3 net sales of $5.14B, up 1.5%, but GAAP net income fell to $582M. Adjusted EPS declined to $0.73. The company lowered its 2026 sales growth forecast to 4.25% and adjusted EPS guidance to $3.16-$3.18. Q4 sales are expected to fall 1-3%. CEO Mike Mahoney cited challenges, including a cybersecurity incident. Cardiovascular division sales rose 1.9%, while Asia-Pacific sales declined 1.1%.
How this was made
The 30-second read
Why it matters
The guidance reduction and earnings decline suggest near‑term earnings pressure, but new product clearances could provide upside later in the year.
Market read
The guidance cut is a primary catalyst for BSX's immediate price move and may influence sentiment across the med‑tech sector.
What to watch
Potential upside from recent regulatory clearance for kidney‑stone and peripheral‑artery devices may mitigate revenue pressure.
Background
Boston Scientific reported a modest rise in net sales but a decline in GAAP net income and adjusted EPS, while highlighting ongoing recovery from a cybersecurity breach.
Ticker impact
Boston Scientific cut its full-year sales outlook and lowered adjusted EPS guidance, causing shares to open over 9% lower.
likely pressure as the market prices in the lower sales and EPS outlook
The company announced a reduced full‑year sales growth target (≈4.25%) and EPS range ($3.16‑$3.18) after a quarterly earnings decline, which historically triggers sell‑offs in medical‑technology stocks.
Market effects
May weigh on broader med‑tech and healthcare equipment sector as peers could be re‑rated.
US healthcare stocks could see modest pullback; European and Asian med‑tech markets may mirror sentiment.
Limited to healthcare sector, no broad market impact.
Counterpoint
If the cybersecurity incident is resolved quickly, the guidance cut could be seen as overly cautious, offering a buying opportunity on dip.
Key entities
- ExecutiveMike Mahoney
CEO of Boston Scientific, commented on the challenging year and cybersecurity recovery.
